OnKure Therapeutics (OKUR) Change in Acquisitions & Divestments (2020 - 2024)

OnKure Therapeutics (OKUR) has 4 years of Change in Acquisitions & Divestments data on file, last reported at -$113.1 million in Q4 2024.

• Quarterly Change in Acquisitions & Divestments fell 239.6% year-over-year to -$113.1 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $15.9 million (down 93.42% YoY) and the FY2024 annual result came in at $15.9 million, down 93.42% from the prior year.
• Change in Acquisitions & Divestments retreated to -$113.1 million in Q4 2024, from $25.0 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $81.0 million in Q4 2023 to a low of -$113.1 million in Q4 2024.
• A 4-year average of $20.6 million and a median of $21.5 million in 2022 frame the typical range for Change in Acquisitions & Divestments.
• Annual changes were most pronounced in 2023 — Change in Acquisitions & Divestments jumped 1216.67% — and 2024, when it plunged 239.6%.
• Tracing OKUR's Change in Acquisitions & Divestments over 4 years: stood at $1.2 million in 2020, then jumped by 533.33% to $7.6 million in 2022, then jumped by 965.79% to $81.0 million in 2023, then sank by 239.6% to -$113.1 million in 2024.
• The last three Change in Acquisitions & Divestments figures came in at -$113.1 million (Q4 2024), $25.0 million (Q3 2024), and $45.0 million (Q2 2024), per Business Quant data.